Boston Scientific Corporation Message Board
-
I would like to take part in the next dilution to buy in my shorts, the last dilution took the stock from 10-12 range down to 7-8 range. The next dilution should take us down to 3-4 I expect. With this new drug they now have something to spend money on and not garner enough in sales to offset there spend. When will they next be at the Wall Street Begging bowl for more money!
Sentiment: Strong Sell
-
A good day to exit this loser. The broader market is seriously outperforming this garbage stock. Go buy the SPY and you will at least make money. SUPN is going to $2 when they burn through more cash and eventually dilute in 2013. That is their expertise, burning through cash! Dump this dog while you can.
Sentiment: Strong Sell
-
You bought a cheap stock that is getting cheaper. Don't forget how much cash this company burns through per year. $5 we will see a bounce at that IPO price. With more share dilution in 2013 this should be a $2 stock in a year.
Sentiment: Strong Sell
-
Maybe this simplifies things for you and why you need to be out of this stock: management
Sentiment: Strong Sell
-
So if one party bought, another party sold. It doesn't matter. The stock will bounce at its IPO price of $5 and that is where I will cover shorts. Remember, this company only spends money and makes nothing. They spend a lot of money and Wall Street is already pricing in the next dilution of equity. This company has grim prospects for years to come
Sentiment: Strong Sell
-
Can you name any institutions that bought at $8.00? No because they sell the shares to investors who do not do their due diligence. All are now taking a bath in red ink so this stock cannot go higher. $5 original IPO price will be the next stop. Wall street is already pricing in their next offering in 2013 when again they will need more cash.
Sentiment: Strong Sell
-
You need to understand who runs the company. I will bet they are already going around wall street looking for more money, expect even more shares to be offered next year at an even lower price the way this company spends money. One dilution leads to another wall street is not dumb!
-
$2 is the next stop. You can see they are financing all of their risky ventures with equity and overpaying their executives. Get out now if you know what is good for you.
Sentiment: Strong Sell
- Reply to
IPO @ $5 huge lockup and now I am suppose to pay $8---I will pass
by fynanc_101 •Nov 30, 2012 8:38 AMThis company is essentially selling generic drugs. They should be valued at about $2/share. This is a company with two generic drugs, go buy Teva if you want a real company.
-
It seems like some expectations are being baked in for this thermoplasty next year having a real effect on earnings.
Anyone know how many procedures they did in 2012 to expect this big increase in sales of Bronchial Thermoplasty?Sentiment: Buy
- Reply to
FILES FOR BANKRUPTCY ANY DAY NOW TIMBERRRRRRRRRRRRRRRRRRR
by pharmaheroja •Sep 20, 2012 11:25 AMYou have nothing to back this up with except that you are short. This is a well run company with one drug already approved. Stock is on the rise!
Sentiment: Buy
-
You still in this stock? looks like the 17 jobs for sales managers are no longer there given the delays. Any near term movers for this stock or is it dead until the next PDUFA in October.
And don't tell me J&J is going to buy them out -
Any chance Trokendi gets approved before some of these JNJ patent expirations? The company guided Q3 2013 but sometimes these get moved along faster then expected for an upside surprise.
-
This company seems fairly valued given they will not launch Trokendi before Q3 2013. Is it possible they launch Trokendi before that date as the orange book lists a Dec. 22 expiration also. Anyone know if this drug will be approved before then? If not it is a long way away from revenue.
The other oxcarbazpine drug has issues with its data from what I heard so I don't want to count on that for revenue.